| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |